A detailed history of Seven Eight Capital, LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Seven Eight Capital, LP holds 64,883 shares of NBIX stock, worth $8.86 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
64,883
Previous 7,862 725.27%
Holding current value
$8.86 Million
Previous $1.08 Million 590.3%
% of portfolio
0.71%
Previous 0.12%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$114.58 - $153.15 $6.53 Million - $8.73 Million
57,021 Added 725.27%
64,883 $7.47 Million
Q2 2024

Aug 12, 2024

BUY
$130.86 - $143.19 $810,023 - $886,346
6,190 Added 370.22%
7,862 $1.08 Million
Q1 2024

May 13, 2024

SELL
$130.4 - $143.74 $722,807 - $796,750
-5,543 Reduced 76.83%
1,672 $230,000
Q4 2023

Feb 13, 2024

BUY
$106.07 - $132.76 $765,295 - $957,863
7,215 New
7,215 $950,000
Q2 2023

Aug 14, 2023

BUY
$89.53 - $104.87 $575,677 - $674,314
6,430 New
6,430 $606,000
Q4 2022

Feb 13, 2023

BUY
$106.72 - $127.06 $192,522 - $229,216
1,804 New
1,804 $215,000
Q4 2021

Feb 14, 2022

SELL
$79.65 - $106.22 $288,014 - $384,091
-3,616 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$86.18 - $99.03 $311,626 - $358,092
3,616 New
3,616 $347,000
Q4 2020

Feb 09, 2021

SELL
$86.91 - $108.33 $1.76 Million - $2.2 Million
-20,300 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$96.16 - $135.15 $1.95 Million - $2.74 Million
20,300 New
20,300 $1.95 Million
Q1 2020

May 14, 2020

SELL
$75.11 - $113.76 $4.96 Million - $7.51 Million
-66,038 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$86.8 - $118.57 $778,509 - $1.06 Million
8,969 Added 15.72%
66,038 $7.1 Million
Q3 2019

Nov 14, 2019

BUY
$83.82 - $101.5 $4.78 Million - $5.79 Million
57,069 New
57,069 $5.14 Million
Q4 2018

Feb 14, 2019

SELL
$68.32 - $124.36 $1.98 Million - $3.61 Million
-29,000 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$98.88 - $125.85 $2.87 Million - $3.65 Million
29,000 New
29,000 $3.57 Million
Q1 2018

May 14, 2018

SELL
$75.88 - $92.43 $2.39 Million - $2.91 Million
-31,500 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$58.53 - $77.59 $1.84 Million - $2.44 Million
31,500
31,500 $2.44 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.